Several months ago, this project began with a simple question about NAD optimization. The goal was straightforward: test intelligently, measure outcomes, and document everything in a structured way.
That narrow focus did not last long.
As I began mapping what truly drives long-term health and performance, the scope expanded quickly. NAD led to biomarkers. Biomarkers led to genetics. Genetics led to deeper questions about how fixed biological architecture shapes everything downstream.
What started as a supplement experiment evolved into a full-scale investigation of whole genome sequencing, DNA interpretation platforms, RNA analysis, and longitudinal lab testing.
That evolution became MyBioHackJourney, a data-driven platform designed to evaluate advanced consumer health technologies in a deliberate and transparent way.
If you are building a serious health baseline, you do not start with surface metrics.
You start with your genome.
Why 30× Whole Genome Sequencing Comes First
Different DNA platforms serve different purposes.
Wearables capture real-time behavioral data. Bloodwork reflects current physiology. Microbiome testing provides functional snapshots. Consumer DNA platforms like 23andMe and Ancestry are excellent for ancestry mapping, family matching, and high-level trait reporting.
Whole genome sequencing serves a different objective.
Instead of sampling selected variants, 30× whole genome sequencing reads essentially your entire genome, roughly 3 billion base pairs, with depth and redundancy for accuracy.
At 30× coverage, each region is read approximately thirty times to improve reliability and reduce sequencing error.
This is not about one approach being superior. It is about use case.
For a project centered on long-term health optimization, clinical integration, and layered interpretation over time, full whole genome sequencing provides the strongest foundation.
That is why Sequencing.com is leading this series.
For this phase, I selected the Professional Ultra Rapid Bundle, which includes:
• 30× whole genome sequencing
• Two to three week ultra-rapid processing
• One month of Professional membership
• 30 health reports
• A clinician-ready AI summary
If this platform is going to serve as the genomic backbone of the project, it needed to be comprehensive from the start.
Sequencing.com Bundle Options Explained
Sequencing.com currently offers three primary bundle tiers, each discounted and structured around report depth and processing speed.
Rare Disease Month Special Bundle (Entry Tier)
Currently discounted from $539 to $379.
Includes:
• 30× whole genome sequencing
• Standard processing
• One month Premium membership
• 12 health reports
• Next-Gen Disease Screen covering 15,000+ conditions
• Core overviews including cancer risk, cardiovascular health, and brain health
• Three bonus reports
This is the lowest-cost entry into full 30× whole genome sequencing. Importantly, sequencing depth remains identical across all tiers.
Expedited Bundle (Mid Tier)
Currently discounted 40 percent.
Includes:
• 30× whole genome sequencing
• Expedited processing
• One month Premium membership
• 20 health reports
In addition to the entry-tier reports, this package expands into:
• Gut health
• Reproductive health
• Autoimmune insights
• Medication and drug response
At this level, genomic reporting moves beyond disease screening and into more system-specific interpretation.
Professional Ultra Rapid Bundle (Top Tier)
Currently discounted from $1,699 to approximately $799.
This is the package I chose.
Includes:
• 30× whole genome sequencing
• Ultra-rapid 2–3 week turnaround
• One month Professional membership
• 30 health reports
• Advanced AI analysis
• Clinician-ready summary report
• Free shipping
Again, sequencing depth is identical across all tiers. What changes at the Professional level is the breadth of reporting and how usable the information becomes.
Additional reporting categories include:
• Oral health
• Skin biology
• Vision health
• Connective tissue markers
• Pediatric and family planning insights
You also receive a structured AI-generated summary designed to support conversations with healthcare providers.
For a project centered on clinical dialogue and cross-disciplinary review, that reporting layer is meaningful.
Ordering, Shipping, and DNA Collection Process
The onboarding process was straightforward.
After selecting a bundle, checkout functions like any other online purchase. Standard shipping is free and quoted at four to ten days. My kit arrived in four.
The package arrives in a simple cardboard box labeled “Sequencing,” without identifying which bundle you selected.
Inside is an easy-to-use cheek swab DNA collection kit.
The process is simple:
• Swab each cheek
• Insert swabs into the provided tube
• Snap and seal
• Place into the included bag
• Insert into the prepaid return envelope
• Drop it in the mail
No lab appointment. No clinic visit. No complexity.
From a user-experience standpoint, it could not have been easier.
Turnaround Time and Initial Results
The Professional Ultra Rapid bundle quotes a two to three week turnaround. My results were delivered in roughly two weeks.
When the notification arrived, I opened the dashboard immediately.
This is not a single PDF report. It is a comprehensive platform.
The results include:
• AI-driven Health Scan
• Next-Gen Disease Screen
• Genome Explorer interface
• 30 individual health reports
• Professional clinician summary
The scope is significant. It will take several days to move through it methodically.
With the current promotional pricing of $795, the investment is meaningful. Even at first glance, however, the depth and breadth of the data justify the cost. This provides a genomic baseline far beyond what I initially anticipated.
Whole Genome Sequencing vs Consumer DNA Tests
A common question is how 30× whole genome sequencing compares to consumer DNA platforms like 23andMe or Ancestry.
Those services are strong, particularly for ancestry insights, family lineage mapping, and accessible trait reports. For many individuals, they are an excellent introduction to personal genetics.
Most consumer kits, however, rely on genotyping arrays that analyze selected variants rather than sequencing the entire genome.
Whole genome sequencing reads approximately 3 billion base pairs of DNA. At 30× coverage, each region is read multiple times to improve accuracy and reliability.
Genotyping provides targeted insight.
Whole genome sequencing provides comprehensive architecture.
Both approaches have value. They simply serve different objectives.
For building a long-term, health-focused genomic baseline that can be reinterpreted as science evolves, full sequencing offers a broader analytical ceiling.
Professional-Level Reporting and Medical Review
At the Professional tier, the advantage is not sequencing depth. It is structured interpretation and clinical usability.
The expanded report library and AI-generated clinician summary are designed to support real-world medical conversations rather than standalone curiosity.
Over the next two weeks, I will be meeting with members of my medical team, including my psychiatrist, my dermatologist, my DPC physician, and my functional medicine provider, to review the results.
The objective is clear: determine what is clinically relevant, what warrants follow-up, and what is simply informative background data.
I will share their insights in upcoming follow-up posts as part of this multi-part Sequencing.com review series.
This Is Part One
So far, the entire experience with Sequencing.com has been smooth and problem-free. Ordering was straightforward. Shipping was fast. Collection was simple. Processing time aligned with expectations.
Now the real analysis begins.
The screening layer has already surfaced several potential rare-condition signals. That does not mean diagnosis. It means structured flags that require interpretation and context.
Over the next two weeks, I will:
• Break down the AI Health Scan in detail
• Analyze the Next-Gen Disease Screen findings
• Compare automated genomic insights with medical provider interpretation
• Separate signal from noise
• Evaluate what is actionable versus informational
This post establishes the baseline.
Part Two will move deeper into the findings.
If you want to see how 30× whole genome sequencing performs beyond marketing language and into real-world clinical review, stay tuned